Geneva, Dec. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12625001392459) titled 'The Effect of Red Light on Cognitive Function in Alzheimer's and Parkinson's Disease' on Dec. 11.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Other
Type of endpoint: Efficacy
Primary Sponsor: National Institute of Integrative Medicine
Condition:
Alzheimer's Disease
Parkinson's Disease
Alzheimer's Disease
Parkinson's Disease
Neurological - Alzheimer's disease
Neurological - Parkinson's disease
Intervention:
All participants will receive:
Photobiomodulation (PBM) will be applied using the WellRed Duo Coronet (ht...